To then understand if depleting Tregs could result in a synergistic effect in combination with Flt3L and CD40 agonist, E0771-tumor bearing mice were treated with Flt3L, CD40 agonist and anti-CD25 to deplete Tregs. The gene discussed is CD40; the disease is neoplasm.